Search Within

Larry Norton

  1. "Body Imaging Service"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (16)
  3. Conference Paper (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)
  2. Body Imaging Service (36)
  3. Breast Medicine Service (36)
  4. Department of Medicine (36)
  5. Radiology, Department of (36)
  6. Solid Tumor Oncology Division (36)

More Groups

People
  1. Clifford Hudis (30)
  2. Maria Theodoulou-Haber (15)
  3. Andrew Seidman (14)
  4. Mary Ellen Moynahan (13)
  5. Sujata Patil (13)
  6. Shanu Modi (10)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2015 (2)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Cancer Research (7)
  3. Breast Cancer Research and Treatment (5)
  4. Clinical Breast Cancer (2)
  5. Annals of Oncology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (8)
  3. Springer (5)
  4. Elsevier Inc. (4)
  5. American Medical Association (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study
    Journal Article

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Mendelson, D.; Solit, D. B.; Bagatell, R.; Ma, W.; Wheler, J.; Rosen, N.; Norton, L.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Optimizing chemotherapy administration: A phase I study of biweekly capecitabine dose and schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Panageas, K.; Hodgman, E.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer
    Journal Article

    Modi, S.; Panageas, K. S.; Duck, E. T.; Bach, A.; Weinstock, N.; Dougherty, J.; Cramer, L.; Hudis, C.; Norton, L.; Seidman, A.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
    Journal Article

    Van Poznak, C.; Seidman, A. D.; Reidenberg, M. M.; Moasser, M. M.; Sklarin, N.; Van Zee, K.; Borgen, P.; Gollub, M.; Bacotti, D.; Yao, T. J.; more...
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Weekly (W) herceptin (H) and taxol (T) for metastatic breast cancer (MBC): Correlation of response rate to HER2 immunophenotype (immunohistochemistry (IHC)) and gene amplification (fluorescent in-situ hybridization (FISH))
    Meeting Abstract

    Fornier, M.; Seidman, A. D.; Esteva, F.; Tan, L.; Kaptain, S.; Bach, A.; Arroyo, C. D.; Hortobagyi, G.; Norton, L.; Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Phase II trial of weekly 1-hour taxol and herceptin for metastatic breast cancer: Toward further exploitation of proven synergistic antitumor activity
    Meeting Abstract

    Seidman, A. D.; Fornier, M.; Hudis, C.; Theodoulou, M.; Surbone, A.; Moynahan, M. E.; Currie, V.; Moasser, M.; Chin, J.; Bach, A.; more...
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
    Journal Article

    Seidman, A. D.; Hudis, C. A.; Albanel, J.; Tong, W.; Tepler, I.; Currie, V.; Moynahan, M. E.; Theodoulou, M.; Gollub, M.; Baselga, J.; more...
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save